Marshall Wace’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $807K | Buy |
201,651
+46,880
| +30% | +$188K | ﹤0.01% | 1816 |
|
|
2025
Q1 | $492K | Buy |
+154,771
| New | +$492K | ﹤0.01% | 1972 |
|
|
2024
Q4 | – | Sell |
-323,211
| Closed | -$1.71M | – | 2448 |
|
|
2024
Q3 | $1.71M | Buy |
323,211
+248,652
| +333% | +$1.31M | ﹤0.01% | 1318 |
|
|
2024
Q2 | $136K | Buy |
+74,559
| New | +$136K | ﹤0.01% | 2152 |
|
|
2023
Q4 | – | Sell |
-198,220
| Closed | -$289K | – | 1905 |
|
|
2023
Q3 | $289K | Sell |
198,220
-100,920
| -34% | -$147K | ﹤0.01% | 1596 |
|
|
2023
Q2 | $685K | Buy |
+299,140
| New | +$685K | ﹤0.01% | 1489 |
|